COVID-19 Impact on Global Renal Disease Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 96 pages | ID: C5D4B7F5F4C3EN
QYResearch

Abstracts

This report focuses on the global Renal Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Renal Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott
• Amgen
• Baxter
• Bristol-Myers Squibb Company
• Keryx Biopharmaceuticals
• NephroGenex
• Novartis AG
• Pfizer
• Sanofi
• Shire Pharmaceuticals Limited
• CTI BioPharma Corp
• Merck
• Prolong Pharmaceuticals
• VESSL Therapeutics

Market segment by Type, the product can be split into

• Acute Kidney Problems
• Chronic Kidney Diseases
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Research Center
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Renal Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Renal Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Renal Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Renal Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Renal Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Acute Kidney Problems
  1.4.3 Chronic Kidney Diseases
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Renal Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Research Center
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Renal Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Renal Disease Treatment Industry
    1.6.1.1 Renal Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Renal Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Renal Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Renal Disease Treatment Market Perspective (2015-2026)
2.2 Renal Disease Treatment Growth Trends by Regions
  2.2.1 Renal Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Renal Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Renal Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Renal Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Renal Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Renal Disease Treatment Players by Market Size
  3.1.1 Global Top Renal Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Renal Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Renal Disease Treatment Market Concentration Ratio
  3.2.1 Global Renal Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Renal Disease Treatment Revenue in 2019
3.3 Renal Disease Treatment Key Players Head office and Area Served
3.4 Key Players Renal Disease Treatment Product Solution and Service
3.5 Date of Enter into Renal Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Renal Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Renal Disease Treatment Forecasted Market Size by Type (2021-2026)

5 RENAL DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Renal Disease Treatment Market Size by Application (2015-2020)
5.2 Global Renal Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Renal Disease Treatment Market Size (2015-2020)
6.2 Renal Disease Treatment Key Players in North America (2019-2020)
6.3 North America Renal Disease Treatment Market Size by Type (2015-2020)
6.4 North America Renal Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Renal Disease Treatment Market Size (2015-2020)
7.2 Renal Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Renal Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Renal Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Renal Disease Treatment Market Size (2015-2020)
8.2 Renal Disease Treatment Key Players in China (2019-2020)
8.3 China Renal Disease Treatment Market Size by Type (2015-2020)
8.4 China Renal Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Renal Disease Treatment Market Size (2015-2020)
9.2 Renal Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Renal Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Renal Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Renal Disease Treatment Market Size (2015-2020)
10.2 Renal Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Renal Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Renal Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Renal Disease Treatment Market Size (2015-2020)
11.2 Renal Disease Treatment Key Players in India (2019-2020)
11.3 India Renal Disease Treatment Market Size by Type (2015-2020)
11.4 India Renal Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Renal Disease Treatment Market Size (2015-2020)
12.2 Renal Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Renal Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Renal Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Renal Disease Treatment Introduction
  13.1.4 Abbott Revenue in Renal Disease Treatment Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Amgen
  13.2.1 Amgen Company Details
  13.2.2 Amgen Business Overview and Its Total Revenue
  13.2.3 Amgen Renal Disease Treatment Introduction
  13.2.4 Amgen Revenue in Renal Disease Treatment Business (2015-2020)
  13.2.5 Amgen Recent Development
13.3 Baxter
  13.3.1 Baxter Company Details
  13.3.2 Baxter Business Overview and Its Total Revenue
  13.3.3 Baxter Renal Disease Treatment Introduction
  13.3.4 Baxter Revenue in Renal Disease Treatment Business (2015-2020)
  13.3.5 Baxter Recent Development
13.4 Bristol-Myers Squibb Company
  13.4.1 Bristol-Myers Squibb Company Company Details
  13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.4.3 Bristol-Myers Squibb Company Renal Disease Treatment Introduction
  13.4.4 Bristol-Myers Squibb Company Revenue in Renal Disease Treatment Business (2015-2020)
  13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Keryx Biopharmaceuticals
  13.5.1 Keryx Biopharmaceuticals Company Details
  13.5.2 Keryx Biopharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Keryx Biopharmaceuticals Renal Disease Treatment Introduction
  13.5.4 Keryx Biopharmaceuticals Revenue in Renal Disease Treatment Business (2015-2020)
  13.5.5 Keryx Biopharmaceuticals Recent Development
13.6 NephroGenex
  13.6.1 NephroGenex Company Details
  13.6.2 NephroGenex Business Overview and Its Total Revenue
  13.6.3 NephroGenex Renal Disease Treatment Introduction
  13.6.4 NephroGenex Revenue in Renal Disease Treatment Business (2015-2020)
  13.6.5 NephroGenex Recent Development
13.7 Novartis AG
  13.7.1 Novartis AG Company Details
  13.7.2 Novartis AG Business Overview and Its Total Revenue
  13.7.3 Novartis AG Renal Disease Treatment Introduction
  13.7.4 Novartis AG Revenue in Renal Disease Treatment Business (2015-2020)
  13.7.5 Novartis AG Recent Development
13.8 Pfizer
  13.8.1 Pfizer Company Details
  13.8.2 Pfizer Business Overview and Its Total Revenue
  13.8.3 Pfizer Renal Disease Treatment Introduction
  13.8.4 Pfizer Revenue in Renal Disease Treatment Business (2015-2020)
  13.8.5 Pfizer Recent Development
13.9 Sanofi
  13.9.1 Sanofi Company Details
  13.9.2 Sanofi Business Overview and Its Total Revenue
  13.9.3 Sanofi Renal Disease Treatment Introduction
  13.9.4 Sanofi Revenue in Renal Disease Treatment Business (2015-2020)
  13.9.5 Sanofi Recent Development
13.10 Shire Pharmaceuticals Limited
  13.10.1 Shire Pharmaceuticals Limited Company Details
  13.10.2 Shire Pharmaceuticals Limited Business Overview and Its Total Revenue
  13.10.3 Shire Pharmaceuticals Limited Renal Disease Treatment Introduction
  13.10.4 Shire Pharmaceuticals Limited Revenue in Renal Disease Treatment Business (2015-2020)
  13.10.5 Shire Pharmaceuticals Limited Recent Development
13.11 CTI BioPharma Corp
  10.11.1 CTI BioPharma Corp Company Details
  10.11.2 CTI BioPharma Corp Business Overview and Its Total Revenue
  10.11.3 CTI BioPharma Corp Renal Disease Treatment Introduction
  10.11.4 CTI BioPharma Corp Revenue in Renal Disease Treatment Business (2015-2020)
  10.11.5 CTI BioPharma Corp Recent Development
13.12 Merck
  10.12.1 Merck Company Details
  10.12.2 Merck Business Overview and Its Total Revenue
  10.12.3 Merck Renal Disease Treatment Introduction
  10.12.4 Merck Revenue in Renal Disease Treatment Business (2015-2020)
  10.12.5 Merck Recent Development
13.13 Prolong Pharmaceuticals
  10.13.1 Prolong Pharmaceuticals Company Details
  10.13.2 Prolong Pharmaceuticals Business Overview and Its Total Revenue
  10.13.3 Prolong Pharmaceuticals Renal Disease Treatment Introduction
  10.13.4 Prolong Pharmaceuticals Revenue in Renal Disease Treatment Business (2015-2020)
  10.13.5 Prolong Pharmaceuticals Recent Development
13.14 VESSL Therapeutics
  10.14.1 VESSL Therapeutics Company Details
  10.14.2 VESSL Therapeutics Business Overview and Its Total Revenue
  10.14.3 VESSL Therapeutics Renal Disease Treatment Introduction
  10.14.4 VESSL Therapeutics Revenue in Renal Disease Treatment Business (2015-2020)
  10.14.5 VESSL Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Renal Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Renal Disease Treatment Revenue
Table 3. Ranking of Global Top Renal Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Renal Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Kidney Problems
Table 6. Key Players of Chronic Kidney Diseases
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Renal Disease Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Renal Disease Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Renal Disease Treatment Players to Combat Covid-19 Impact
Table 13. Global Renal Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Renal Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Renal Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Renal Disease Treatment Market Share by Regions (2015-2020)
Table 17. Global Renal Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Renal Disease Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Renal Disease Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Renal Disease Treatment Players
Table 24. Global Renal Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Renal Disease Treatment Market Share by Players (2015-2020)
Table 26. Global Top Renal Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Disease Treatment as of 2019)
Table 27. Global Renal Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Renal Disease Treatment Product Solution and Service
Table 30. Date of Enter into Renal Disease Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Renal Disease Treatment Market Size Share by Type (2015-2020)
Table 34. Global Renal Disease Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Renal Disease Treatment Market Size Share by Application (2015-2020)
Table 36. Global Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Renal Disease Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Renal Disease Treatment Market Share (2019-2020)
Table 40. North America Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Renal Disease Treatment Market Share by Type (2015-2020)
Table 42. North America Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Renal Disease Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Renal Disease Treatment Market Share (2019-2020)
Table 46. Europe Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Renal Disease Treatment Market Share by Type (2015-2020)
Table 48. Europe Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Renal Disease Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Renal Disease Treatment Market Share (2019-2020)
Table 52. China Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Renal Disease Treatment Market Share by Type (2015-2020)
Table 54. China Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Renal Disease Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Renal Disease Treatment Market Share (2019-2020)
Table 58. Japan Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Renal Disease Treatment Market Share by Type (2015-2020)
Table 60. Japan Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Renal Disease Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Renal Disease Treatment Market Share (2019-2020)
Table 64. Southeast Asia Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Renal Disease Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Renal Disease Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Renal Disease Treatment Market Share (2019-2020)
Table 70. India Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Renal Disease Treatment Market Share by Type (2015-2020)
Table 72. India Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Renal Disease Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Renal Disease Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Renal Disease Treatment Market Share (2019-2020)
Table 76. Central & South America Renal Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Renal Disease Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Renal Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Renal Disease Treatment Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Product
Table 88. Amgen Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 89. Amgen Recent Development
Table 90. Baxter Company Details
Table 91. Baxter Business Overview
Table 92. Baxter Product
Table 93. Baxter Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 94. Baxter Recent Development
Table 95. Bristol-Myers Squibb Company Company Details
Table 96. Bristol-Myers Squibb Company Business Overview
Table 97. Bristol-Myers Squibb Company Product
Table 98. Bristol-Myers Squibb Company Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Keryx Biopharmaceuticals Company Details
Table 101. Keryx Biopharmaceuticals Business Overview
Table 102. Keryx Biopharmaceuticals Product
Table 103. Keryx Biopharmaceuticals Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 104. Keryx Biopharmaceuticals Recent Development
Table 105. NephroGenex Company Details
Table 106. NephroGenex Business Overview
Table 107. NephroGenex Product
Table 108. NephroGenex Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 109. NephroGenex Recent Development
Table 110. Novartis AG Company Details
Table 111. Novartis AG Business Overview
Table 112. Novartis AG Product
Table 113. Novartis AG Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 114. Novartis AG Recent Development
Table 115. Pfizer Business Overview
Table 116. Pfizer Product
Table 117. Pfizer Company Details
Table 118. Pfizer Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 119. Pfizer Recent Development
Table 120. Sanofi Company Details
Table 121. Sanofi Business Overview
Table 122. Sanofi Product
Table 123. Sanofi Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 124. Sanofi Recent Development
Table 125. Shire Pharmaceuticals Limited Company Details
Table 126. Shire Pharmaceuticals Limited Business Overview
Table 127. Shire Pharmaceuticals Limited Product
Table 128. Shire Pharmaceuticals Limited Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 129. Shire Pharmaceuticals Limited Recent Development
Table 130. CTI BioPharma Corp Company Details
Table 131. CTI BioPharma Corp Business Overview
Table 132. CTI BioPharma Corp Product
Table 133. CTI BioPharma Corp Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 134. CTI BioPharma Corp Recent Development
Table 135. Merck Company Details
Table 136. Merck Business Overview
Table 137. Merck Product
Table 138. Merck Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 139. Merck Recent Development
Table 140. Prolong Pharmaceuticals Company Details
Table 141. Prolong Pharmaceuticals Business Overview
Table 142. Prolong Pharmaceuticals Product
Table 143. Prolong Pharmaceuticals Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 144. Prolong Pharmaceuticals Recent Development
Table 145. VESSL Therapeutics Company Details
Table 146. VESSL Therapeutics Business Overview
Table 147. VESSL Therapeutics Product
Table 148. VESSL Therapeutics Revenue in Renal Disease Treatment Business (2015-2020) (Million US$)
Table 149. VESSL Therapeutics Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Renal Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acute Kidney Problems Features
Figure 3. Chronic Kidney Diseases Features
Figure 4. Others Features
Figure 5. Global Renal Disease Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Center Case Studies
Figure 9. Other Case Studies
Figure 10. Renal Disease Treatment Report Years Considered
Figure 11. Global Renal Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Renal Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Renal Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Renal Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Renal Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Renal Disease Treatment Revenue in 2019
Figure 18. North America Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Renal Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 29. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Baxter Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 31. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bristol-Myers Squibb Company Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 33. Keryx Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Keryx Biopharmaceuticals Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 35. NephroGenex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. NephroGenex Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 37. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis AG Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 39. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Pfizer Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 41. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sanofi Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 43. Shire Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Shire Pharmaceuticals Limited Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 45. CTI BioPharma Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. CTI BioPharma Corp Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 47. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Merck Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 49. Prolong Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Prolong Pharmaceuticals Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 51. VESSL Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. VESSL Therapeutics Revenue Growth Rate in Renal Disease Treatment Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed